​

Vivos Therapeutics (VVOS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

VVOS Stock Forecast

Vivos Therapeutics (VVOS) stock forecast, based on 5 Wall Street analysts, predicts a 12-month average price target of $2.13, with a high of $2.50 and a low of $1.75. This represents a 153.57% increase from the last price of $0.84.

- $3 $6 $9 $12 $15 High: $2.5 Avg: $2.13 Low: $1.75 Last Closed Price: $0.84

VVOS Stock Rating

Vivos Therapeutics stock's rating consensus is Buy, based on 5 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 5 0 5 Strong Sell Sell Hold Buy Strong Buy

VVOS Price Target Upside V Benchmarks

TypeNameUpside
StockVivos Therapeutics153.57%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks30.52%

Price Target Trends

1M3M12M
# Anlaysts223
Avg Price Target$2.13$2.13$2.17
Last Closing Price$0.84$0.84$0.84
Upside/Downside153.57%153.57%158.33%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 26-21--3
Mar, 26-21--3
Feb, 26-21--3
Jan, 26-21--3
Dec, 25-21--3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 17, 2026H.C. Wainwright$2.50$1.01147.52%197.62%
Apr 17, 2026Industrial Alliance Securities$1.75$1.0075.00%108.33%
May 20, 2025Scott HenryIndustrial Alliance Securities$2.25$2.154.65%167.86%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 20, 2025Alliance Global PartnersBuyNeutraldowngrade
Apr 01, 2025Alliance Global PartnersBuyBuyhold

Financial Forecast

EPS Forecast

$-30 $-24 $-18 $-12 $-6 $0 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25
Dec 21Dec 22Dec 23Dec 24Dec 25
Reported$-23.89$-25.90$-11.14$-2.22-
Avg Forecast$-22.50$-26.50$-10.52$-2.02$-1.07
High Forecast$-22.50$-25.94$-10.20$-1.96$-1.03
Low Forecast$-22.50$-27.06$-10.83$-2.08$-1.10
Surprise %6.18%-2.26%5.89%9.90%-

Revenue Forecast

$14M $15M $16M $17M $19M $20M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25
Dec 21Dec 22Dec 23Dec 24Dec 25
Reported$16.89M$16.02M$13.80M$15.03M$17.44M
Avg Forecast$17.30M$16.55M$13.98M$15.20M$19.16M
High Forecast$17.30M$16.82M$14.30M$15.55M$19.60M
Low Forecast$17.30M$16.28M$13.66M$14.85M$18.72M
Surprise %-2.40%-3.17%-1.30%-1.12%-8.95%

Net Income Forecast

$-35M $-28M $-21M $-14M $-7M $0 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25
Dec 21Dec 22Dec 23Dec 24Dec 25
Reported$-20.29M$-23.84M$-13.58M$-11.14M-
Avg Forecast$-27.44M$-32.31M$-12.82M$-2.46M$-1.30M
High Forecast$-27.44M$-31.63M$-12.44M$-2.39M$-1.26M
Low Forecast$-27.44M$-33.00M$-13.20M$-2.54M$-1.34M
Surprise %-26.04%-26.21%5.94%352.10%-

VVOS Forecast FAQ

Is Vivos Therapeutics stock a buy?

Vivos Therapeutics stock has a consensus rating of Buy, based on 5 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Vivos Therapeutics is a favorable investment for most analysts.

What is Vivos Therapeutics's price target?

Vivos Therapeutics's price target, set by 5 Wall Street analysts, averages $2.13 over the next 12 months. The price target range spans from $1.75 at the low end to $2.5 at the high end, suggesting a potential 153.57% change from the previous closing price of $0.84.

How does Vivos Therapeutics stock forecast compare to its benchmarks?

Vivos Therapeutics's stock forecast shows a 153.57% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (30.52%).

What is the breakdown of analyst ratings for Vivos Therapeutics over the past three months?

  • April 2026: 0% Strong Buy, 66.67% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.
  • March 2026: 0% Strong Buy, 66.67% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 0% Strong Buy, 66.67% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.